The rapid industrialization and growth of modern society have improved the quality of life for many, but they have also posed significant health and environmental challenges. At Evogene we offer access to our Computational Predictive Biology (CPB) platform, fusing biological science, Big Data, and AI. Our tech-engines, MicroBoost AI, ChemPass AI, and GeneRator AI, empower scientists, agriculturalists, and researchers to efficiently discover solutions in life science industries like medicine, pharmaceuticals, and agriculture, and optimize the probability of success and reduce time and cost during the development process. With our technology, changemakers can decode biology to enhance global health, well-being, and the environment. Our subsidiaries, research division, and business partners generate impactful solutions across multiple industries.
Evogene is driven to shape a better future for humanity and the environment. Our commitment to environmental, social and governance (ESG) impact is not only at the core of how we do business; it inspires our identity as a company and the way we engage with all of our global stakeholders.
Minimizing negative impacts on the environment and minimizing the use of resources by enabling the efficient generation of solutions empowered by nature.
Spearheading access to novel life science product developments for the betterment of human health, pioneering smarter industrial processes, and taking responsibility by acting with fairness and decency towards our employees.
Conducting our business in full compliance and transparency, while encouraging a diverse working environment, guided by our core principles.
Harnessing the full scale of humanity’s biological knowledge to power scalable solutions across multiple industries is no easy task. That’s why we focus our powerful tech-engines at three levels: microbes, small molecules, and genetic elements that can be used to generate novel and nature-based solutions to some of the greatest challenges to human health and environmental sustainability. Our business is conducted through our dedicated subsidiary companies, research divisions, and through our business partners that work with us on joint development of additional products using our solutions.
Food security and the livelihoods of global farmers are threatened by modern societal and production-related stressors. We tackle these challenges by leveraging our extensive scientific expertise in plant biology, disease control, and insect mechanisms affecting yield, stress tolerance, and more. Our vast proprietary genomic data from 200+ plant species and tailored microbial data fuel our nature-based agricultural solutions.
for the development of microbiome-based ag-biological products to support sustainable agriculture practices.
for the development of a new mode of action for crop protection products, ag-chemicals, pesticide resistance and herbicides with better environmental impacts.
for the development of oil-seed crops with high carbon-dioxide assimilation and increased drought tolerance.
We support the discovery and implementation of agricultural products and solutions that enable the maintenance of ecosystems, strengthen the capacity for adaptation to climate change, extreme weather, drought, and other natural phenomena, and that can improve land and soil quality while increasing productivity and production.
Modern technology has improved the quality of life for many but has taken a toll on the environment due to unsustainable production and consumption. Exploring alternative energy sources for industry is a meaningful way to combat these environmental issues.
Our subsidiary, Casterra Ag., focuses on efficient castor oil production to serve as a clean fuel additive, reducing emissions by replacing a portion of fossil fuels.
We support increasing resource-use efficiency and adopting clean and environmentally sound technologies to fuel more sustainable industrial processes, inspired by biology.
We focus on streamlining life science product development to enhance healthcare access and improve clinical outcomes by addressing key health conditions. We leverage our expertise in microbe, human-microbiome, and small molecule solutions to discover novel pharmaceutical treatments and natural remedies.
for the development of human microbiome-based therapeutics, for antibiotic-resistant bacteria, immuno-oncology, and microbiome-related gastrointestinal (GI) disorders.
We aim to enhance human health and well-being by enabling the delivery of impactful life science products. Our Engines of Enablement, as described below, strive to increase the success rate and efficiency of healthcare solutions while reducing time-to-market and costs for novel life science products.
